Legal & General Group PLC Brooklyn Immuno Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 22, 2022
SELL
$0.48 - $2.03 $1,444 - $6,108
-3,009 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$8.86 - $17.05 $5,032 - $9,684
568 Added 23.27%
3,009 $28,000
Q2 2021

Aug 12, 2021
BUY
$3.75 - $78.5 $9,153 - $191,618
2,441 New
2,441 $44,000

Others Institutions Holding BTX

# of Institutions
1
Shares Held
1.21M
Call Options Held
0
Put Options Held
0
View Full List

About Brooklyn ImmunoTherapeutics, Inc.

BTX Quotes by TradingView
  • Ticker BTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,825,700
  • Description
  • Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...
More about BTX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email